UK Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The United Kingdom Drug Delivery Devices Market is segmented By Route of Administration (Injectable, Topical and Others), Application and End-user

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2019
CAGR: 22.81 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The United Kingdom drug delivery devices market is anticipated to expand at a CAGR of 22.81% over the forecast period. The rising prevalence of chronic diseases, technological advancements, growth in the biologics market are some of the key factors driving the growth of the United Kingdom drug delivery devices market. 

Drug delivery devices help in delivering the drugs which are beneficial for the targeted population to recover faster. The usage of these drug delivery devices reduces the chances of side effects by improving the drug present at the target site. This helps in reducing the dose and associated side effects. In addition, this helps in reducing the overall product price by reducing the amount of active pharmaceutical ingredient.

In addition, a rising number of cancers, respiratory are diabetic patients across the region will promote the adoption of drug delivery devices and drive the overall market. As per GLOBOCAN, around 446.94 thousand cancer cases were reported in the United Kingdom in the year 2018. The presence of a huge target population will require regular drug delivery devices for diagnosis and treatment purposes and propel the drug delivery devices market. Moreover, Increasing R&D expenditure by innovators and generic players, the development of new drugs and biologics and technological advancements in understanding human biology and diseases will also fuel the overall market.

Scope of the report

As per the scope, the United Kingdom drug delivery devices or system are the tools which are used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. The UK Drug Delivery Devices Market is segmented By Route of Administration, Application, and End-user.

Report scope can be customized per your requirements. Click here.

Key Market Trends

By Route of Administration, Topical Drug Delivery Devices is Estimated to Witness a Healthy Growth in Future.

Topical drug delivery devices are estimated to witness healthy growth in the future attributed to several benefits associated with this type of route of administration such as ease of use, painless, noninvasive delivery, convenient and superior spreadability. Moreover, the increasing prevalence of skin diseases in the United Kingdom also likely to bolster the market growth. As per the Institute for Health Metrics and Evaluation, in 2019, there were 22.66 million regional populations were having a skin infections. This rising prevalence and enhanced patient compliance will likely positively impact segment growth. In addition, a rising number of biopharmaceutical R&D expenditure will also boost the growth of the United Kingdom drug delivery devices market


Competitive Landscape

The United Kingdom Drug Delivery Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Pfizer Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Becton, Dickinson and Company, 3M among others.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancements Coupled with Rapidly Growing Biologics Market

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Needlestick Injuries

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Route of Administration

      1. 5.1.1 Injectable

      2. 5.1.2 Topical

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Cancer

      2. 5.2.2 Cardiovascular

      3. 5.2.3 Diabetes

      4. 5.2.4 Infectious diseases

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others


    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Novartis AG

      3. 6.1.3 F. Hoffmann-La Roche Ltd

      4. 6.1.4 Johnson & Johnson Services, Inc

      5. 6.1.5 3M

      6. 6.1.6 Becton, Dickinson and Company

      7. 6.1.7 Baxter International Inc.

      8. 6.1.8 Teva Pharmaceutical Industries Ltd

      9. 6.1.9 Mylan N.V.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The United Kingdom Drug Delivery Devices Market market is studied from 2018 - 2026.

The United Kingdom Drug Delivery Devices Market is growing at a CAGR of 22.81% over the next 5 years.

Becton, Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd, Novartis, Mylan NV are the major companies operating in United Kingdom Drug Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!